Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
1 clinical trials · Condition
◉ Watch Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))
| Record | Firm | Date |
|---|---|---|
| A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) (NCT07430202) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2026-08-01 |
Track Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC)) automatically
Every clearance here is in the API, with alerts when new ones post.